| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | CN102317320A Fusion protein capable of binding VEGF-A and TNF-alpha |
| 01/11/2012 | CN102311503A Recombinant human serum albumin / FGF fusion protein with continuous effect on restoration of a plurality of skin cells |
| 01/11/2012 | CN102311502A Fusion protein used for inhibiting regeneration or growth of blood vessel and medical treatment application thereof |
| 01/11/2012 | CN102311501A Fusion protein comprising GLP-1 (Glucagon-Like Peptide) or analog thereof and preparation method as well as application thereof |
| 01/11/2012 | CN102311500A Antiviral fusion protein and application thereof |
| 01/11/2012 | CN102311493A Peptide inhibiting telomerase activity, its preparation method and application |
| 01/11/2012 | CN101948853B Thermophilic fat bacillus DNA polymerase |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2221342C A method and nucleotide sequence for transforming microorganisms |
| 01/05/2012 | WO2012003281A2 Small-molecule-targeted protein degradation |
| 01/05/2012 | WO2012002562A1 Modified protein therapeutics |
| 01/05/2012 | WO2012000458A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 01/05/2012 | WO2012000187A1 Fusion protein of g-csf variant, preparation method and use thereof |
| 01/05/2012 | WO2012000118A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | WO2011142858A3 Chlorotoxin variants, conjugates, and methods for their use |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | US20120005776 Nonviral vectors for delivering polynucleotides to plants |
| 01/05/2012 | US20120004398 Method for Uses of Protein Precursors as Prodrugs |
| 01/05/2012 | US20120004393 Potent Compstatin Analogs |
| 01/05/2012 | US20120003299 Novel hsp90-targeted anti-cancer chimeric peptide |
| 01/05/2012 | US20120003269 Compositions Produced Using Enteric Pathogens and Methods of Use |
| 01/05/2012 | US20120003259 Molecule |
| 01/05/2012 | US20120003249 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 01/05/2012 | US20120003248 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
| 01/05/2012 | US20120003241 Vaccine against botulism |
| 01/05/2012 | US20120003237 Wise binding agents and epitopes |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003222 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 01/05/2012 | US20120003221 Human serum albumin linkers and conjugates thereof |
| 01/05/2012 | US20120003210 NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| 01/05/2012 | US20120003201 Vault agents for chronic kidney disease |
| 01/05/2012 | CA2803646A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
| 01/04/2012 | EP2401302A1 Antibodies containing therapeutic tpo/epo mimetic peptides |
| 01/04/2012 | EP2046831B1 Novel multivalent immunoglobulins |
| 01/04/2012 | CN1944460B Alr polypeptide and application thereof |
| 01/04/2012 | CN1896108B Preparation of specific anticoagulation matter and its use |
| 01/04/2012 | CN102307905A Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
| 01/04/2012 | CN102307904A Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 01/04/2012 | CN102307903A Novel semi-synthetic glycopeptides as antibacterial agents |
| 01/04/2012 | CN102305855A Reagent and method for detecting Mycobacterium tuberculosis infection in vitro |
| 01/04/2012 | CN102304536A Eukaryotic fused expression product of two marine animal antibacterial peptide genes, and preparation method thereof |
| 01/04/2012 | CN102304185A Fusion protein surface immunogenic protein-target of RNA III activating protein (SIP-TRAP) for preventing bovine mastitis and preparation method and use thereof |
| 01/04/2012 | CN101273134B Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes and method |
| 01/03/2012 | US8088389 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2475604C An herpes simplex virus complex |
| 01/03/2012 | CA2347025C Zinc finger binding domains for gnn |
| 01/03/2012 | CA2224468C P53 protein variants and therapeutical uses thereof |
| 01/03/2012 | CA2178482C Thrombopoietin |
| 12/29/2011 | WO2011162492A2 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
| 12/29/2011 | WO2011161244A1 Homodimeric protein constructs |
| 12/29/2011 | US20110319602 T2r taste receptors and genes encoding same |
| 12/29/2011 | US20110319596 Hybrid vegetable protein and method for obtaining same |
| 12/29/2011 | US20110319337 Dominant Negative WNT2 Compositions and Methods of Use |
| 12/29/2011 | US20110319327 Polypeptides Homologous to VEGF and BMP1 |
| 12/29/2011 | US20110318834 Multiple-tumor aberrant growth genes |
| 12/29/2011 | US20110318779 Process for producing recombinant protein using novel fusion partner |
| 12/29/2011 | US20110318362 Novel card proteins involved in cell death regulation |
| 12/29/2011 | US20110318357 Methods and compositions based on shiga toxin type 2 protein |
| 12/29/2011 | US20110318318 Anti-apoptotic fusion proteins |
| 12/29/2011 | US20110318306 Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology |
| 12/29/2011 | CA2805449A1 Treatment of sanfilippo syndrome type b |
| 12/29/2011 | CA2803391A1 Colon and pancreas cancer specific antigens and antibodies |
| 12/29/2011 | CA2803058A1 Homodimeric protein constructs |
| 12/28/2011 | EP2399939A2 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof |
| 12/28/2011 | EP2399925A1 Method for fluorescently labeling protein |
| 12/28/2011 | CN102300585A 包含血红蛋白受体的脑膜炎球菌疫苗 Meningococcal vaccine comprising the hemoglobin receptor |
| 12/28/2011 | CN102295701A 抗胸腺素α原多克隆抗体及其制备方法与应用 Former anti-thymosin α polyclonal antibody preparation method and application |
| 12/27/2011 | US8084021 Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects |
| 12/25/2011 | CA2708753A1 Peptide diagnostic agent for lyme disease |
| 12/22/2011 | WO2011160026A2 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures |
| 12/22/2011 | WO2011159847A2 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof |
| 12/22/2011 | WO2011159741A2 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 12/22/2011 | WO2011159735A2 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 12/22/2011 | WO2011159369A1 Nuclease activity of tal effector and foki fusion protein |
| 12/22/2011 | WO2011094584A3 Method and system for purifying and quantitating proteins using heme fusion tags |
| 12/22/2011 | US20110314565 Method for Isolating Cell-Type Specific mRNAS |
| 12/22/2011 | US20110313132 Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 12/22/2011 | US20110312893 Method for isolating neural cells with tenascin-r compounds |
| 12/22/2011 | US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 12/22/2011 | US20110312877 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use |
| 12/22/2011 | US20110312872 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 12/22/2011 | US20110312104 Immunoassay method |
| 12/22/2011 | US20110312059 Tau protease compositions and methods |
| 12/22/2011 | US20110312027 Production of Carrier-Peptide Conjugates Using Chemically Reactive Unnatural Amino Acids |
| 12/22/2011 | US20110311566 Methods and materials for generating t cells |
| 12/22/2011 | US20110311561 Non-natural mic proteins |
| 12/22/2011 | US20110311558 Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases |
| 12/22/2011 | US20110311540 Wisp polypeptides and nucleic acids encoding same |
| 12/22/2011 | US20110311536 Prevention of type 1 diabetes by treg vaccination with an insulin mimetope |
| 12/22/2011 | US20110311534 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 12/22/2011 | US20110311533 Regulation of protein level |
| 12/22/2011 | US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 12/22/2011 | US20110311530 Truncated baff receptors |
| 12/22/2011 | US20110311499 Secretion System and Methods for its Use |
| 12/22/2011 | US20110311484 Strains of xenotropic murine leukemia-related virus and methods for detection thereof |
| 12/22/2011 | US20110311454 Molecules with extended half-lives, compositions and uses thereof |